These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 33599685)

  • 1. The Price of Success-How to Evaluate COVID-19 Vaccines When They're Available Outside of Clinical Trials.
    Rubin R
    JAMA; 2021 Mar; 325(10):918-921. PubMed ID: 33599685
    [No Abstract]   [Full Text] [Related]  

  • 2. Search for better COVID vaccines confounded by existing rollouts.
    Dolgin E
    Nature; 2021 Jan; 589(7842):340-341. PubMed ID: 33420405
    [No Abstract]   [Full Text] [Related]  

  • 3. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    Rid A; Lipsitch M; Miller FG
    JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
    [No Abstract]   [Full Text] [Related]  

  • 4. Problematic Covid-19 vaccine trials in times of vaccine nationalism.
    Ravinetto R
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion of children and pregnant women in COVID-19 intervention trials.
    Malhotra A; Kumar A; Roehr CC; den Boer MC
    Pediatr Res; 2021 Apr; 89(5):1063-1064. PubMed ID: 32688370
    [No Abstract]   [Full Text] [Related]  

  • 6. "No" to placebo-controlled trials of Covid-19 vaccines.
    Ahmad A; Dhrolia MF
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethics and Professionalism on the Frontline: Controlled Human Infection Trials in COVID-19 Vaccine Development: Ethical Considerations.
    Lucido C
    S D Med; 2020 Oct; 73(10):490-492. PubMed ID: 33264530
    [No Abstract]   [Full Text] [Related]  

  • 8. Trials for second generation Covid-19 vaccines: Revisiting the debate over placebo use in developing country clinical trials.
    Lurie P
    Indian J Med Ethics; 2021; VI(2):1-10. PubMed ID: 33908352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraordinary diseases require extraordinary solutions.
    Plotkin SA; Caplan A
    Vaccine; 2020 May; 38(24):3987-3988. PubMed ID: 32331807
    [No Abstract]   [Full Text] [Related]  

  • 10. New placebo-controlled Covid-19 vaccine trials are ethically questionable; it's now about comparative effectiveness and availability of registered vaccines.
    Knottnerus JA
    J Clin Epidemiol; 2021 May; 133():175-176. PubMed ID: 33741502
    [No Abstract]   [Full Text] [Related]  

  • 11. How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine.
    Shakir S; Lane S; Davies M
    Drug Saf; 2021 Jan; 44(1):1-5. PubMed ID: 33219926
    [No Abstract]   [Full Text] [Related]  

  • 12. New challenges emerge for planned human challenge trials.
    Cornwall W
    Science; 2020 Dec; 370(6521):1150. PubMed ID: 33273082
    [No Abstract]   [Full Text] [Related]  

  • 13. Trial participants' rights after authorisation of COVID-19 vaccines.
    Dal-Ré R; Orenstein W; Caplan AL
    Lancet Respir Med; 2021 Apr; 9(4):e30-e31. PubMed ID: 33476582
    [No Abstract]   [Full Text] [Related]  

  • 14. Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.
    Bianchi DW; Kaeser L; Cernich AN
    JAMA; 2021 Mar; 325(11):1041-1042. PubMed ID: 33566088
    [No Abstract]   [Full Text] [Related]  

  • 15. Avoiding exploitation in multinational covid-19 vaccine trials.
    Iyer AA; Millum J; Grady C; Wendler D
    BMJ; 2021 Mar; 372():n541. PubMed ID: 33664082
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective vaccine offers shot of hope for pandemic.
    Cohen J
    Science; 2020 Nov; 370(6518):748-749. PubMed ID: 33184184
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
    Joffe S
    JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069
    [No Abstract]   [Full Text] [Related]  

  • 18. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 vaccination in immunocompromised patients.
    Sonani B; Aslam F; Goyal A; Patel J; Bansal P
    Clin Rheumatol; 2021 Feb; 40(2):797-798. PubMed ID: 33426632
    [No Abstract]   [Full Text] [Related]  

  • 20. The lightning-fast quest for COVID vaccines - and what it means for other diseases.
    Ball P
    Nature; 2021 Jan; 589(7840):16-18. PubMed ID: 33340018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.